Last reviewed · How we verify
NCT03613311
Evident, Occult and no Demonstrated USI and UDS Findings in Women With ≥Stage II Cystocele
trial testing Urodynamic study in Urodynamic Stress Incontinence in Severe Cystocele Women in 480 participants. Completed in 31 May 2018.
31 January 2017
Quick facts
| Lead sponsor | National Taiwan University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 480 |
| Start date | 1 November 2011 |
| Primary completion | 31 January 2017 |
| Estimated completion | 31 May 2018 |
Drugs / interventions tested
- Urodynamic study
Conditions studied
- Urodynamic Stress Incontinence in Severe Cystocele Women — all drugs for Urodynamic Stress Incontinence in Severe Cystocele Women →
Sponsor
National Taiwan University Hospital
Who can join
20 and older, female only, with Urodynamic Stress Incontinence in Severe Cystocele Women. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prevalence rates of urodynamic urinary incontinence (USI) subtypes and their related clinical and urodynamic findings in women with ≥ pelvic organ prolapse quantification stage II cystocele are important for clinical consultation, especially for occult USI. Misdiagnosis of occult USI before cystocele repair might lead to occurrence of de novo stress urinary incontinence after cystocele repair. Thus, the aim of this study was to elucidate the above findings and between-group associations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03613311
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Urodynamic study
Trials testing the same drug.
- NCT04835766 — Urodynamic Changes Following Bladder Injury · unknown
- NCT04793126 — Clinical and Urodynamic Evaluation of Surgical Repair of Pelvic Organ Prolapse Associated With Lower Urinary Tract Sympt · Phase 2 · completed
- NCT04184128 — Detrusor Underactivity and Bladder Outlet Obstruction in Women With Cystocele · completed
- NCT04981080 — DU and BOO in Women With and Without Symptoms of VD · completed
- NCT04184752 — Prevalence of Detrusor Underactivity and Bladder Outlet Obstruction in Female Without Cystocele · completed
Other National Taiwan University Hospital trials
Trials by the same sponsor.
- NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
- NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
- NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
- NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
- NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03613311 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
- Last refreshed: 3 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03613311.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing